logo

NRXP

NRX Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.62 / 10
Netural

Fund-flow data reveal a good score of 7.87/10, with positive trends in block and extra-large inflows, despite negative signals in small and medium flows. This implies institutional accumulation is present, supporting the stock. Analyst coverage is limited to three opinions, all rating it Strong Buy, but historical win rates vary widely (0% to 50%), and the current price trend is falling (-9.91%). The combination of strong conviction but mixed historical performance suggests that while sentiment is positive, it is not yet fully reflected in the price.

FundamentalSentiment(5.62)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-01-02
InstitutionAscendiant Capital
Times predicted3
Historical Win Rate33.3%
Is money flowing into or out of NRXP?
  • NRXP holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.62/10 (Netural).